Skip to main content
. 2022 Jan 3;9:780045. doi: 10.3389/fped.2021.780045

Table 3.

Self-reported respiratory- and voice symptoms between groups of adults born EP with- or without LVCP and EP-born controls.

PDA-surgery EP-born controls
Symptoms LVCP
N = 14
No LVCP
N = 13
OP
N = 3
p a N = 23 p b
Hoarse voice, n (%) 8 (57) 1 (8) 3 (100) 0.01 3 (13) 0.09
Voice affects participation in singing, n (%) 8 (57) 1 (8) 3 (100) 0.01
Voice that cracks when shouting, n (%) 7 (50) 2 (15) 3 (100) 0.10
Weak or unclear voice which limits the possibility for being heard in a noisy environment, n (%) 8 (57) 4 (31) 3 (100) 0.25
Voice affects participation in school-work or social activities, n (%) 4 (29) 3 (23) 3 (100) 1.00
None of the symptoms above, n (%) 2 (14) 9 (69) 0 (0) 0.006
Asthma medications last 12 months, n (%) 3 (21) 1 (8) 1 (33) 0.60 4 (17) 1.00
Breathing problems beyond normal during normal physical exertion, n (%) 9 (64) 6 (46) 3 (100) 0.45 7 (30) 0.09
“Scraping” sound or abnormal sounds during physical exertion, n (%) 6 (42) 2 (15) 2 (67) 0.21 2 (9) 0.09

EP, extremely preterm (gestational age <28 weeks and/or birthweight <1,000 g); LVCP, left vocal cord paralysis; OP, other pathology; PDA, patent ductus arteriosus. p) Fisher's exact test

a

LVCP vs. no LVCP;

b

PDA-surgery group (LVCP + no LVCP) vs. EP-born controls.